Front Matter
*Title 1—General Provisions
[View]
Title 2—The Congress
[View]
*Title 3—The President
[View]
*Title 4—Flag And Seal, Seat Of Government, And The States
[View]
*Title 5—Government Organization And Employees; and Appendix
[View]
Title 6—Domestic Security
[View]
Title 7—Agriculture
[View]
Title 8—Aliens And Nationality
[View]
*Title 9—Arbitration
[View]
*Title 10—Armed Forces
[View]
*Title 11—Bankruptcy; and Appendix
[View]
Title 12—Banks And Banking
[View]
*Title 13—Census
[View]
*Title 14—Coast Guard
[View]
Title 15—Commerce And Trade
[View]
Title 16—Conservation
[View]
*Title 17—Copyrights
[View]
*Title 18—Crimes And Criminal Procedure; and Appendix
[View]
Title 19—Customs Duties
[View]
Title 20—Education
[View]
Title 21—Food And Drugs
[View]
 
TITLE 21—Front Matter
[View]
CHAPTER 1—ADULTERATED OR MISBRANDED FOODS OR DRUGS (sections 1 to 26)
[View]
CHAPTER 2—TEAS (sections 41 to 50)
[View]
CHAPTER 3—FILLED MILK (sections 61 to 64)
[View]
CHAPTER 4—ANIMALS, MEATS, AND MEAT AND DAIRY PRODUCTS (sections 71 to 149)
[View]
CHAPTER 5—VIRUSES, SERUMS, TOXINS, ANTITOXINS, AND ANALOGOUS PRODUCTS (sections 151 to 159)
[View]
CHAPTER 5A—BUREAU OF NARCOTICS (sections 161 to 165)
[View]
CHAPTER 6—NARCOTIC DRUGS (sections 171 to 200b)
[View]
CHAPTER 7—PRACTICE OF PHARMACY AND SALE OF POISONS IN CONSULAR DISTRICTS IN CHINA (sections 201 to 215)
[View]
CHAPTER 8—NARCOTIC FARMS (sections 221 to 237)
[View]
CHAPTER 9—FEDERAL FOOD, DRUG, AND COSMETIC ACT (sections 321 to 399i)
[View]
 
CHAPTER 9—Front Matter
[View]
SUBCHAPTER I—SHORT TITLE (section 301)
[View]
SUBCHAPTER II—DEFINITIONS (sections 321 to 321d)
[View]
SUBCHAPTER III—PROHIBITED ACTS AND PENALTIES (sections 331 to 337a)
[View]
SUBCHAPTER IV—FOOD (sections 341 to 350m)
[View]
SUBCHAPTER V—DRUGS AND DEVICES (sections 351 to 360fff-8)
[View]
 
SUBCHAPTER V—Front Matter
[View]
Part A—Drugs and Devices (sections 351 to 360n-2)
[View]
 
Part A—Front Matter
[View]
 
Sec. 351. Adulterated drugs and devices
[View]
 
Sec. 352. Misbranded drugs and devices
[View]
 
Sec. 353. Exemptions and consideration for certain drugs, devices, and biological products
[View]
 
Sec. 353a. Pharmacy compounding
[View]
 
Sec. 353a-1. Enhanced communication
[View]
 
Sec. 353b. Outsourcing facilities
[View]
 
Sec. 353c. Prereview of television advertisements
[View]
 
Sec. 353d. Process to update labeling for certain generic drugs
[View]
 
Sec. 354. Veterinary feed directive drugs
[View]
 
Sec. 355. New drugs
[View]
 
Sec. 355-1. Risk evaluation and mitigation strategies
[View]
 
Sec. 355-2. Actions for delays of generic drugs and biosimilar biological products
[View]
 
Sec. 355a. Pediatric studies of drugs
[View]
 
Sec. 355b. Adverse-event reporting
[View]
 
Sec. 355c. Research into pediatric uses for drugs and biological products
[View]
 
Sec. 355c-1. Report
[View]
 
Sec. 355d. Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
[View]
 
Sec. 355e. Pharmaceutical security
[View]
 
Sec. 355f. Extension of exclusivity period for new qualified infectious disease products
[View]
 
Sec. 355g. Utilizing real world evidence
[View]
 
Sec. 355h. Regulation of certain nonprescription drugs that are marketed without an approved drug application
[View]
 
Sec. 356. Expedited approval of drugs for serious or life-threatening diseases or conditions
[View]
 
Sec. 356-1. Accelerated approval of priority countermeasures
[View]
 
Sec. 356-2. Accelerated approval Council
[View]
 
Sec. 356a. Manufacturing changes
[View]
 
Sec. 356b. Reports of postmarketing studies
[View]
 
Sec. 356c. Discontinuance or interruption in the production of life-saving drugs
[View]
 
Sec. 356c-1. Annual reporting on drug shortages
[View]
 
Sec. 356d. Coordination; task force and strategic plan
[View]
 
Sec. 356e. Drug shortage list
[View]
 
Sec. 356f. Hospital repackaging of drugs in shortage
[View]
 
Sec. 356g. Standards for regenerative medicine and regenerative advanced therapies
[View]
 
Sec. 356h. Competitive generic therapies
[View]
 
Sec. 356i. Prompt reports of marketing status
[View]
 
Sec. 356j. Discontinuance or interruption in the production of medical devices
[View]
 
Sec. 356k. Platform technologies
[View]
 
Sec. 356l. Advanced manufacturing technologies designation program
[View]
 
Sec. 357. Qualification of drug development tools
[View]
 
Sec. 358. Authority to designate official names
[View]
 
Sec. 359. Nonapplicability of subchapter to cosmetics
[View]
 
Sec. 360. Registration of producers of drugs or devices
[View]
 
Sec. 360a. Clinical trial guidance for antibiotic drugs
[View]
 
Sec. 360a-1. Clinical trials
[View]
 
Sec. 360a-2. Susceptibility test interpretive criteria for microorganisms
[View]
 
Sec. 360b. New animal drugs
[View]
 
Sec. 360b-1. Priority zoonotic animal drugs
[View]
 
Sec. 360c. Classification of devices intended for human use
[View]
 
Sec. 360c-1. Reporting
[View]
 
Sec. 360d. Performance standards
[View]
 
Sec. 360e. Premarket approval
[View]
 
Sec. 360e-1. Pediatric uses of devices
[View]
 
Sec. 360e-3. Breakthrough devices
[View]
 
Sec. 360e-4. Predetermined change control plans for devices
[View]
 
Sec. 360f. Banned devices
[View]
 
Sec. 360g. Judicial review
[View]
 
Sec. 360g-1. Agency documentation and review of significant decisions regarding devices
[View]
 
Sec. 360g-2. Third party data transparency
[View]
 
Sec. 360h. Notification and other remedies
[View]
 
Sec. 360h-1. Program to improve the device recall system
[View]
 
Sec. 360i. Records and reports on devices
[View]
 
Sec. 360j. General provisions respecting control of devices intended for human use
[View]
 
Sec. 360k. State and local requirements respecting devices
[View]
 
Sec. 360l. Postmarket surveillance
[View]
 
Sec. 360m. Accredited persons
[View]
 
Sec. 360n. Priority review to encourage treatments for tropical diseases
[View]
 
Sec. 360n-1. Priority review for qualified infectious disease products
[View]
 
Sec. 360n-2. Ensuring cybersecurity of devices
[View]
Part B—Drugs for Rare Diseases or Conditions (sections 360aa to 360ff-1)
[View]
Part C—Electronic Product Radiation Control (sections 360hh to 360ss)
[View]
Part D—Dissemination of Treatment Information (sections 360aaa to 360aaa-6)
[View]
Part E—General Provisions Relating to Drugs and Devices (sections 360bbb to 360bbb-8d)
[View]
Part F—New Animal Drugs for Minor Use and Minor Species (sections 360ccc to 360ccc-2)
[View]
Part G—Medical Gases (sections 360ddd to 360ddd-2)
[View]
Part H—Pharmaceutical Distribution Supply Chain (sections 360eee to 360eee-4)
[View]
Part I—Nonprescription Sunscreen and Other Active Ingredients (sections 360fff to 360fff-8)
[View]
SUBCHAPTER VI—COSMETICS (sections 361 to 364j)
[View]
SUBCHAPTER VII—GENERAL AUTHORITY (sections 371 to 379dd-2)
[View]
SUBCHAPTER VIII—IMPORTS AND EXPORTS (sections 381 to 384g)
[View]
SUBCHAPTER IX—TOBACCO PRODUCTS (sections 387 to 387v)
[View]
SUBCHAPTER X—MISCELLANEOUS (sections 391 to 399i)
[View]
CHAPTER 10—POULTRY AND POULTRY PRODUCTS INSPECTION (sections 451 to 473)
[View]
CHAPTER 11—MANUFACTURE OF NARCOTIC DRUGS (sections 501 to 517)
[View]
CHAPTER 12—MEAT INSPECTION (sections 601 to 695)
[View]
CHAPTER 13—DRUG ABUSE PREVENTION AND CONTROL (sections 801 to 971)
[View]
CHAPTER 14—ALCOHOL AND DRUG ABUSE EDUCATIONAL PROGRAMS AND ACTIVITIES (sections 1001 to 1007)
[View]
CHAPTER 15—EGG PRODUCTS INSPECTION (sections 1031 to 1056)
[View]
CHAPTER 16—DRUG ABUSE PREVENTION, TREATMENT, AND REHABILITATION (sections 1101 to 1194)
[View]
CHAPTER 17—NATIONAL DRUG ENFORCEMENT POLICY (sections 1201 to 1204)
[View]
CHAPTER 18—PRESIDENT'S MEDIA COMMISSION ON ALCOHOL AND DRUG ABUSE PREVENTION (sections 1301 to 1308)
[View]
CHAPTER 19—PESTICIDE MONITORING IMPROVEMENTS (sections 1401 to 1403)
[View]
CHAPTER 20—NATIONAL DRUG CONTROL PROGRAM (sections 1501 to 1536)
[View]
CHAPTER 21—BIOMATERIALS ACCESS ASSURANCE (sections 1601 to 1606)
[View]
CHAPTER 22—NATIONAL DRUG CONTROL POLICY (sections 1701 to 1715)
[View]
CHAPTER 23—NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN (sections 1801 to 1804)
[View]
CHAPTER 24—INTERNATIONAL NARCOTICS TRAFFICKING (sections 1901 to 1908)
[View]
CHAPTER 25—MISCELLANEOUS ANTI-DRUG ABUSE PROVISIONS (sections 2001 to 2014)
[View]
CHAPTER 26—FOOD SAFETY (sections 2101 to 2110)
[View]
CHAPTER 27—FOOD SAFETY MODERNIZATION (sections 2201 to 2252)
[View]
CHAPTER 28—SANCTIONS WITH RESPECT TO FOREIGN TRAFFICKERS OF ILLICIT SYNTHETIC OPIOIDS (sections 2301 to 2335)
[View]
CHAPTER 28A—FENTANYL ERADICATION AND NARCOTICS DETERRENCE OFF FENTANYL (sections 2341 to 2355)
[View]
CHAPTER 29—INTERNATIONAL SPORTS DOPING (sections 2401 to 2404)
[View]
Title 22—Foreign Relations And Intercourse
[View]
*Title 23—Highways
[View]
Title 24—Hospitals And Asylums
[View]
Title 25—Indians
[View]
Title 26—Internal Revenue Code
[View]
Title 27—Intoxicating Liquors
[View]
*Title 28—Judiciary And Judicial Procedure; and Appendix
[View]
Title 29—Labor
[View]
Title 30—Mineral Lands And Mining
[View]
*Title 31—Money And Finance
[View]
*Title 32—National Guard
[View]
Title 33—Navigation And Navigable Waters
[View]
Title 34—Crime Control And Law Enforcement
[View]
*Title 35—Patents
[View]
*Title 36—Patriotic And National Observances, Ceremonies, And Organizations
[View]
*Title 37—Pay And Allowances Of The Uniformed Services
[View]
*Title 38—Veterans' Benefits
[View]
*Title 39—Postal Service
[View]
*Title 40—Public Buildings, Property, And Works
[View]
*Title 41—Public Contracts
[View]
Title 42—The Public Health And Welfare
[View]
Title 43—Public Lands
[View]
*Title 44—Public Printing And Documents
[View]
Title 45—Railroads
[View]
*Title 46—Shipping
[View]
Title 47—Telecommunications
[View]
Title 48—Territories And Insular Possessions
[View]
*Title 49—Transportation
[View]
Title 50—War And National Defense; and Appendix
[View]
*Title 51—National And Commercial Space Programs
[View]
Title 52—Voting And Elections
[View]
Title 53—[Reserved]
[View]
*Title 54—National Park Service And Related Programs
[View]
 Popular Names and Tables
[View]
submit